166 related articles for article (PubMed ID: 37906166)
21. Modeling the Potential of Treg-Based Therapies for Transplant Rejection: Effect of Dose, Timing, and Accumulation Site.
Lapp MM; Lin G; Komin A; Andrews L; Knudson M; Mossman L; Raimondi G; Arciero JC
Transpl Int; 2022; 35():10297. PubMed ID: 35479106
[No Abstract] [Full Text] [Related]
22. Prevention of allogeneic cardiac graft rejection by transfer of ex vivo expanded antigen-specific regulatory T-cells.
Takasato F; Morita R; Schichita T; Sekiya T; Morikawa Y; Kuroda T; Niimi M; Yoshimura A
PLoS One; 2014; 9(2):e87722. PubMed ID: 24498362
[TBL] [Abstract][Full Text] [Related]
23. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
24. The role of regulatory T cells in liver transplantation.
Beyzaei Z; Shojazadeh A; Geramizadeh B
Transpl Immunol; 2022 Feb; 70():101512. PubMed ID: 34871717
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-derived Suppressor Cells Recruit CD4(+)/Foxp3(+) Regulatory T Cells in a Murine Cardiac Allograft.
Nakamura T; Nakao T; Ashihara E; Yoshimura N
Transplant Proc; 2016 May; 48(4):1275-8. PubMed ID: 27320602
[TBL] [Abstract][Full Text] [Related]
26. Thymus-Derived Regulatory T Cells Infiltrate the Cardiac Allograft Before Rejection.
Boer K; Caliskan K; Peeters AM; van Groningen MC; Samsom JN; Maat AP; Betjes MG; Weimar W; Baan CC
Transplantation; 2015 Sep; 99(9):1839-46. PubMed ID: 25886917
[TBL] [Abstract][Full Text] [Related]
27. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
[TBL] [Abstract][Full Text] [Related]
28. Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR(+)-Treg-cells in transplanted patients.
Seissler N; Schmitt E; Hug F; Sommerer C; Zeier M; Schaier M; Steinborn A
Transpl Immunol; 2012 Dec; 27(4):157-61. PubMed ID: 23022208
[TBL] [Abstract][Full Text] [Related]
29. GITR Blockade Facilitates Treg Mediated Allograft Survival.
Sonawane SB; Kim JI; Lee MK; Lee SH; Duff PE; Moore DJ; Lian MM; Deng S; Choi Y; Yeh H; Caton AJ; Markmann JF
Transplantation; 2009 Nov; 88(10):1169-77. PubMed ID: 19935370
[TBL] [Abstract][Full Text] [Related]
30. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
Issa F; Hester J; Goto R; Nadig SN; Goodacre TE; Wood K
Transplantation; 2010 Dec; 90(12):1321-7. PubMed ID: 21048528
[TBL] [Abstract][Full Text] [Related]
31. Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.
Wolf D; Schreiber TH; Tryphonopoulos P; Li S; Tzakis AG; Ruiz P; Podack ER
Transplantation; 2012 Sep; 94(6):569-74. PubMed ID: 22902792
[TBL] [Abstract][Full Text] [Related]
32. Thymic function in HIV-infection.
Kolte L
Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
[TBL] [Abstract][Full Text] [Related]
33. Preventing alloimmune rejection using circular RNA FSCN1-silenced dendritic cells in heart transplantation.
Wang B; Zhou Q; Li T; Li S; Greasley A; Skaro A; Quan D; Min W; Liu K; Zheng X
J Heart Lung Transplant; 2021 Jul; 40(7):584-594. PubMed ID: 34052126
[TBL] [Abstract][Full Text] [Related]
34. Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.
Lim TY; Perpiñán E; Londoño MC; Miquel R; Ruiz P; Kurt AS; Kodela E; Cross AR; Berlin C; Hester J; Issa F; Douiri A; Volmer FH; Taubert R; Williams E; Demetris AJ; Lesniak A; Bensimon G; Lozano JJ; Martinez-Llordella M; Tree T; Sánchez-Fueyo A
J Hepatol; 2023 Jan; 78(1):153-164. PubMed ID: 36087863
[TBL] [Abstract][Full Text] [Related]
35. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
36. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
[TBL] [Abstract][Full Text] [Related]
37. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cell expressed MyD88 is critical for prolongation of allograft survival.
Borges CM; Reichenbach DK; Kim BS; Misra A; Blazar BR; Turka LA
Transpl Int; 2016 Aug; 29(8):930-40. PubMed ID: 27112509
[TBL] [Abstract][Full Text] [Related]
39. The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection.
Schaier M; Seissler N; Becker LE; Schaefer SM; Schmitt E; Meuer S; Hug F; Sommerer C; Waldherr R; Zeier M; Steinborn A
Transpl Int; 2013 Mar; 26(3):290-9. PubMed ID: 23279010
[TBL] [Abstract][Full Text] [Related]
40. A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.
Mathew JM; H-Voss J; LeFever A; Konieczna I; Stratton C; He J; Huang X; Gallon L; Skaro A; Ansari MJ; Leventhal JR
Sci Rep; 2018 May; 8(1):7428. PubMed ID: 29743501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
